3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Active not recruiting
3
Completed
2
Recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Genitourinary
1
Conditions
Prostatic Neoplasms
21
Lymphoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Lymphoma, Large B-Cell, Diffuse
13
Lymphoma, Non-Hodgkin
8
Lymphoma, Follicular
7
Leukemia
6
Hodgkin Disease
6
Neoplasm Metastasis
5
Lymphoma, B-Cell
4
Burkitt Lymphoma
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, B-Cell, Marginal Zone
3
Hemangioma
3
Recurrence
2
Neoplasms
2
Neoplasm, Residual
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Dendritic Cell Sarcoma, Interdigitating
2
Breast Neoplasms
2
Thymoma
1
Stomatitis
1
Prostate Cancer Metastatic
1
Philadelphia Chromosome
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
Gemcitabine
109
Paclitaxel
92
Carboplatin
79
Bevacizumab
75
pembrolizumab
74
Surveys and Questionnaires
70
Docetaxel
69
Cisplatin
67
Nivolumab
48
Exercise
48
Capecitabine
48
Cyclophosphamide
47
Sorafenib
43
Fluorouracil
43
Irinotecan
42
Pemetrexed
37
Albumin-Bound Paclitaxel
35
Radiotherapy
34
Dexamethasone
34
Blood Specimen Collection
34
Oxaliplatin
31
Leucovorin
31
Erlotinib Hydrochloride
31
trametinib
30
130-nm albumin-bound paclitaxel
29
Cetuximab
28
Therapeutics
26
Ipilimumab
26
Standard of Care
25
Methods
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Neoplasms
×
Prednisolone
×
Clear all
NCT00519285
2016-07-22
VENICE
Sanofi
Phase 3
Completed
1,224 enrolled
21 charts
NCT00822809
2012-10-03
CASIMAS
Neovii Biotech
Phase 3
Completed
230 enrolled